See the Complete Picture.

Browser Extension

Sunday, May 18, 2025

US Edition

Subscribe Login

Israel-Hamas Conflict

Natural Disasters

Manchester City

Artificial Intelligence

Prostate Cancer Foundation image

News from Prostate Cancer Foundation

News Home Page Local News Blindspot Feed International Covid-19

International North America South America Europe Asia Australia Africa

Trending Internationally Eurovision Baseball Social Media Natural Disasters Manchester City

Trending in U.S.Israel-Hamas Conflict Baseball NBA NFL Tornado

Trending in U.K.Israel-Hamas Conflict Manchester City Manchester United Premier League Soccer

Trending Topics

Eurovision Baseball Social Media Natural Disasters Israel-Hamas Conflict

CompanyAbout History Mission Blog Testimonials Group Subscriptions Subscribe Gift Free Trial Careers Affiliates

HelpHelp Center FAQ Contact Us For Educators/Libraries Media Bias Ratings Ownership and Factuality Ratings Referral Code News Sources Topics

ToolsApp Browser Extension Daily Newsletter Blindspot Report Newsletter Burst Your Bubble Newsletter Timelines

Gift Privacy Policy Manage Cookies Terms and Conditions

© 2025 Snapwise Inc

Search Blindspot Local

News from Prostate Cancer Foundation

See all of Prostate Cancer Foundation’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources.

In total, 8 have been published by Prostate Cancer Foundation which Ground News has aggregated in the past 3 months.

We’ve assigned a media bias rating of unknown to Prostate Cancer Foundation. You can read more about our methodology here.

We’ve assigned a rating of Unknown factuality to Prostate Cancer Foundation. You can read more about how we’ve determined Prostate Cancer Foundation’s credibility and reliability as a news source here: https://ground.news/rating-system.

See all of Prostate Cancer Foundation’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources. In total, 8 have been published by Prostate Cancer Foundation which Ground News has aggregated in the past 3 months.

We’ve assigned a media bias rating of unknown to Prostate Cancer Foundation. You can read more about our methodology here. We’ve assigned a rating of Unknown factuality to Prostate Cancer Foundation. You can read more about how we’ve determined Prostate Cancer Foundation’s credibility and reliability as a news source here: https://ground.news/rating-system.

Information about Prostate Cancer Foundation

Where is Prostate Cancer Foundation located?Prostate Cancer Foundation's Website Prostate Cancer Foundation's Twitter

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Prostate Cancer Foundation News

High-Impact Conference News in Prostate Cancer

United States · United States

High-Impact Conference News in Prostate Cancer

Prostate cancer researchers, clinicians, and advocates gathered at two big international conferences: the European Association of Urology (EAU) and the American Urological Association (AUA). PCF Chief Medical Officer Dr. Phillip Koo sat down with Dr. Zachary Klaassen (Wellstar MCG Health) to talk about new research findings, and why it’s important for patients and caregivers to stay up to date. Learn about: Important new data from a survey of 5…Read Article

Two-Week Radiotherapy Matches Eight-Week Prostate Cancer Treatment

Maryland · Maryland

Two-Week Radiotherapy Matches Eight-Week Prostate Cancer Treatment

A decade-long phase 3 trial shows 2 week radiotherapy is as safe and effective as 8 week treatment for prostate cancer, with similar survival and side effects.See the Story

You've scrolled to the bottom of the feed, there are no more stories.

FDA Expands Indication for Lutetium Lu 177 Vipivotide Tetraxetan in mCRPC

FDA Expands Indication for Lutetium Lu 177 Vipivotide Tetraxetan in mCRPC

The FDA has expanded the indication for lutetium Lu 177 vipivotide tetraxetan for use in additional patients with PSMA-positive metastatic castration-resistant prostate cancer.United States · United States See the Story

End of the Road for Immune Checkpoint Inhibitors in Prostate Cancer?

End of the Road for Immune Checkpoint Inhibitors in Prostate Cancer?

100% Center coverage: 1 sources

(MedPage Today) -- Adding an immune checkpoint inhibitor (ICI) to chemotherapy for advanced prostate cancer failed to improve survival as compared with chemotherapy alone, according to final results from a large randomized trial. Men with metastatic...See the Story

Top 5 Takeaways for Patients from ASCO GU 2025

Top 5 Takeaways for Patients from ASCO GU 2025

Thousands of clinicians and researchers gathered in February for the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU). Held in San Francisco and online, the conference featured hundreds of studies of prostate cancer treatment, diagnosis, prevention, and survivorship—many led by researchers funded by PCF. For individuals with prostate cancer and their caregivers, here are five key takeaways from ASCO GU 2025. Talazo…San Francisco, California · San Francisco Read Article

#?Singular Genomics Takes a Bold Leap Forward: Acquisition by Deerfield Management Fuels New Era of Genomic Innovation?,

#?Singular Genomics Takes a Bold Leap Forward: Acquisition by Deerfield Management Fuels New Era of Genomic Innovation?,

Singular Genomics Systems, Inc.: A Transformational Shift in the Genomics Landscape Following Acquisition by Deerfield Management SAN DIEGO, Feb. 21, 2025 ' Singular Genomics Systems, Inc. (Nasdaq: OMIC), a trailblazer in the field of next-generation sequencing (NGS) and spatial multiomics technologies, has announced today the closing of its acquisition by an affiliate of Deerfield Management Company, L.P. This acquisition represents a momentous…Cancer · Los Angeles See the Story

Atlanta Hawks Foundation and Ressler Gertz Family Foundation Reach New Milestone with $150,000 Donated to Fight Prostate Cancer

Atlanta Hawks Foundation and Ressler Gertz Family Foundation Reach New Milestone with $150,000 Donated to Fight Prostate Cancer

FOR IMMEDIATE RELEASE: 2/20/25 CONTACT: Max Strauss or Ciara Smith, Atlanta Hawks Brand Communications, brandcomms@hawks.com ATLANTA – Prior to tonight’s game, the Atlanta Hawks Foundation, together with the Ressler Gertz Family Foundation, announced a $150,000 donation to the Prostate Cancer Foundation (PCF) to increase awareness about prostate cancer and raise funds to support groundbreaking research. This season, the Atlanta Hawks Foundation …Maryland · Maryland Read Article